1,242
Views
12
CrossRef citations to date
0
Altmetric
Editorial

Atrial fibrillation and stroke prevention: brief observations on the last decade

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Kannan Sridharan, Rashed Al Banna, Ali Mohamed Qader & Aysha Husain. (2020) Evaluation of inter-patient variability in the pharmacodynamic indices of warfarin. Expert Review of Cardiovascular Therapy 18:11, pages 835-840.
Read now
María Asunción Esteve-Pastor, Vanessa Roldán, Mariano Valdés, Gregory Y. H. Lip & Francisco Marín. (2016) The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation. Expert Review of Cardiovascular Therapy 14:2, pages 177-187.
Read now
Birsen Ince, Gulcin Benbir & Gokcen Gozubatik-Celik. (2014) Should HAS-BLED scoring be revised for better risk estimation in patients with intracerebral hemorrhage?. Expert Review of Cardiovascular Therapy 12:8, pages 929-931.
Read now

Articles from other publishers (9)

Kannan Sridharan, Rashed Al Banna, Zainab Malalla, Aysha Husain, Mai Sater, Ghufran Jassim & Sameer Otoom. (2021) Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study. Pharmacological Reports 73:5, pages 1405-1417.
Crossref
Buqing Ni, Zidun Wang, Weidong Gu, Mingfang Li, Minglong Chen, Gregory Y.H. Lip & Yongfeng Shao. (2021) Thoracoscopic Left Atrial Appendage Excision Plus Ablation for Atrial Fibrillation to Prevent Stroke. Seminars in Thoracic and Cardiovascular Surgery 33:1, pages 61-67.
Crossref
Aníbal García-Sempere, Isabel Hurtado, Daniel Bejarano-Quisoboni, Clara Rodríguez-Bernal, Yared Santa-Ana, Salvador Peiró & Gabriel Sanfélix-Gimeno. (2019) Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world study. PLOS ONE 14:2, pages e0211681.
Crossref
María Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Inmaculada Roldán-Rabadán, Vanessa Roldán, Javier Muñiz, Paula Raña-Míguez, Martín Ruiz-Ortiz, Ángel Cequier, Vicente Bertomeu-Martínez, Lina Badimón, Manuel Anguita, Gregory Y H . Lip & Francisco Marín. (2018) Quality of oral anticoagulation with vitamin K antagonists in ‘real-world’ patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry. EP Europace 20:9, pages 1435-1441.
Crossref
María Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Vanessa Roldán, Esteban Orenes-Piñero, Giulio Francesco Romiti, Imma Romanazzi, Ying Bai, João Carmo, Marco Proietti, Francisco Marín & Gregory Y.H. Lip. (2018) Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated “Real-World” in Patients With Atrial Fibrillation. The American Journal of Cardiology 122:5, pages 785-792.
Crossref
María Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Vanessa Roldán, Vicente Vicente, Giulio Francesco Romiti, Imma Romanazzi, Marco Proietti, Mariano Valdés, Francisco Marín & Gregory Y.H. Lip. (2018) Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in ‘real-world’ atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients. International Journal of Cardiology 254, pages 125-131.
Crossref
Antoni Bayés de Luna & Adrian Baranchuk. 2017. Clinical Arrhythmology. Clinical Arrhythmology 83 163 .
Filip M. Szymanski, Gregory Y.H. Lip, Krzysztof J. Filipiak, Anna E. Platek & Grzegorz Karpinski. (2016) Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea. International Journal of Cardiology 204, pages 200-205.
Crossref
Junyu Chen, Xiaodong Zhuang, Ming Long, Chen Su & Lichun Wang. (2015) Efficacy and Safety of Edoxaban in Nonvalvular Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials. Journal of Stroke and Cerebrovascular Diseases 24:12, pages 2710-2719.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.